Error: Could not add to watchlist. X
+ Watchlist

Regulus Therapeutics Inc

RGLS:US
NASDAQ GM
0.92
USD
0.07
7.58%
As of 8:10 PM EDT 6/23/2017
Open
0.99
Day Range
0.90 - 1.04
Volume
4,554,369
Previous Close
0.99
52Wk Range
0.86 - 5.35
1 Yr Return
-82.70%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.99
Day Range
0.90 - 1.04
Volume
4,554,369
Previous Close
0.99
52Wk Range
0.86 - 5.35
1 Yr Return
-82.70%
YTD Return
-59.33%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.60
Market Cap (m USD)
48.662
Shares Outstanding (m)
53.182
Price/Sales (TTM)
66.83
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas Therapeutics offers its services worldwide.
Address
10614 Science Center Drive
San Diego, CA 92121
United States
Phone
1-858-202-6300
  • Joseph P Hagan "Jay"
    President/CEO
  • Daniel R Chevallard
    Chief Financial Officer
  • Mark Deeg
    Chief Medical Officer
  • Timothy Wright
    Chief Research & Development Ofcr
  • Allison Wey
    VP:IR & Corporate Communications
Show More